Search Results - "Kanegae, Kazuko"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism by Tatsumi, Kohei, Ohashi, Kazuo, Matsubara, Yoshinori, Kohori, Ayako, Ohno, Takahiro, Kakidachi, Hiroshi, Horii, Akihiro, Kanegae, Kazuko, Utoh, Rie, Iwata, Takanori, Okano, Teruo

    “…[Display omitted] ► Systematically injected mesenchymal stem cells cause fatal pulmonary embolism. ► Tissue factor is highly expressed on the cultured…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Identification of biomarkers for predicting the response to cyclosporine A therapy in patients with chronic spontaneous urticaria by Takahiro Endoa, b, Shota Toyoshimaa, c, Kazuko Kanegaea, Satoshi Izakia, Nobuyuki Nishimoria, Mana Itoa, Kazuko Sugaid, e, Koremasa Hayamaa, Tadashi Teruib, Yoshimichi Okayamaa

    Published in Allergology International (01-04-2019)
    “…Dear Editor, Cyclosporine A (CsA) is recommended as a third-line treatment for patients with chronic urticaria (CU) in the guideline of the European Academy of…”
    Get full text
    Journal Article
  8. 8

    In Vivo Analysis of Necrosis and Ferroptosis in Nonalcoholic Steatohepatitis (NASH) by Tsurusaki, Shinya, Kanegae, Kazuko, Tanaka, Minoru

    “…Nonalcoholic steatohepatitis (NASH) is a metabolic liver disease that progresses from simple steatosis to the disease states such as chronic inflammation and…”
    Get more information
    Journal Article
  9. 9

    Establishment of human induced pluripotent stem cell-derived hepatobiliary organoid with bile duct for pharmaceutical research use by Wang, Luyao, Koui, Yuta, Kanegae, Kazuko, Kido, Taketomo, Tamura-Nakano, Miwa, Yabe, Shigeharu, Tai, Kenpei, Nakajima, Yoshiko, Kusuhara, Hiroyuki, Sakai, Yasuyuki, Miyajima, Atsushi, Okochi, Hitoshi, Tanaka, Minoru

    Published in Biomaterials (01-10-2024)
    “…In vitro models of the human liver are promising alternatives to animal tests for drug development. Currently, primary human hepatocytes (PHHs) are preferred…”
    Get full text
    Journal Article
  10. 10

    The non-invasive cell surface modification of hepatocytes with PEG-lipid derivatives by Tatsumi, Kohei, Ohashi, Kazuo, Teramura, Yuji, Utoh, Rie, Kanegae, Kazuko, Watanabe, Natsumi, Mukobata, Shigeki, Nakayama, Masamichi, Iwata, Hiroo, Okano, Teruo

    Published in Biomaterials (01-01-2012)
    “…Abstract Hepatocyte-based therapies are promising regenerative approaches for liver diseases. In this study, we sought to develop a versatile method to modify…”
    Get full text
    Journal Article
  11. 11